热门资讯> 正文

Vir Biotechnology任命Jason O ' Byrne为CFO

2024-09-10 20:32

Vir Biotechnology (NASDAQ:VIR) said it has appointed Jason O’Byrne as its CFO and executive vice president.
The appointment is effective from October 2.
Mr. O’Byrne is an industry veteran with over two decades of experience, and most recently served as the finance chief of Caribou Biosciences.

More on Vir Biotechnology

Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis
Vir announces major restructuring, licensing deal with Sanofi

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。